Show simple item record

dc.contributor.authorSantos-Moreno, Pedro
dc.contributor.authorChavez-Chavez, Josefina
dc.contributor.authorHernández-Zambrano, Sandra Milena
dc.contributor.authorRivera-Triana, Diana Patricia
dc.contributor.authorCastiblanco-Montañez, Ruth Alexandra
dc.contributor.authorAza, Anggie
dc.contributor.authorBuitrago-García, Diana
dc.contributor.authorVillarreal, Laura
dc.contributor.authorRojas-Villarraga, Adriana
dc.date.accessioned2021-07-28T19:50:34Z
dc.publisherBMJ Publishing Groupspa
dc.description.abstractWe have read with interest the work of Bozzalla-Cassione et al1 published recently in your journal regarding the implementation of a telemedicine programme for patients with lupus in northern Italy. It is logical to suppose that the risk of patients with rheumatic diseases of having a more severe clinical course if they become infected with the COVID-19 infection is very high; however, although some of the reports show that there seems to be a low incidence of COVID-19 infection in patients with rheumatic disease, collaborative work with large cohorts is needed, which could show us the real incidence of COVID-19 infection in these patients and what happens with the establishment of telemedicine programmes.2–6 We show an experience in a specialised centre in Bogota, Colombia; currently, we have a cohort of 5597 patients with rheumatoid arthritis (RA) in exclusively ambulatory care. On 12 March 2020, in Colombia, the health emergency by COVID-19 was established and a week later the Ministry of Health ordered the outpatient care procedure for the population in isolation. From that moment on, our institution, carrying out the proper logistical and legal processes, proceeded to convert its ambulatory care services into care through telemedicine.eng
dc.date.issued2021-05
dc.sourcehttps://ard.bmj.com/content/annrheumdis/80/5/e65.full.pdfspa
dc.format.extent1spa
dc.titleExperience of telemedicine use in a big cohort of patients with rheumatoid arthritis during COVID-19 pandemiceng
dc.format.mimetypeapplication/pdfspa
dc.typeArtículo de revistaspa
dc.date.available2021-07-28T19:50:34Z
dc.identifier.urihttps://repositorio.fucsalud.edu.co/handle/001/1644
dc.language.isoengspa
dc.relation.ispartofAnnals of the Rheumatic Diseases ISSN: 0003-4967 Vol..80 Núm.5 (2021)
dc.rights.accessrightsinfo:eu-repo/semantics/openAccessspa
dc.rights.creativecommonsAtribución-NoComercial-SinDerivadas 4.0 Internacional (CC BY-NC-ND 4.0)spa
dc.rights.urihttps://creativecommons.org/licenses/by-nd/4.0/spa
dc.subject.proposalArtritis reumatoidespa
dc.subject.proposalTelemedicinaspa
dc.subject.proposalCOVID-!9spa
dc.subject.proposalPacientesspa
dc.type.coarhttp://purl.org/coar/resource_type/c_6501spa
dc.type.driverinfo:eu-repo/semantics/articlespa
dc.type.versioninfo:eu-repo/semantics/publishedVersionspa
dc.publisher.placeReino Unidospa
dc.relation.citationendpage1spa
dc.relation.citationissue5spa
dc.relation.citationstartpage1spa
dc.relation.citationvolume80spa
dc.relation.ispartofjournalAnnals of the Rheumatic Diseasesspa
dc.type.contentTextspa
dc.type.redcolhttps://purl.org/redcol/resource_type/WPspa
dc.type.coarversionhttp://purl.org/coar/version/c_970fb48d4fbd8a85spa
dc.rights.coarhttp://purl.org/coar/access_right/c_abf2spa


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

info:eu-repo/semantics/openAccess
Except where otherwise noted, this item's license is described as info:eu-repo/semantics/openAccess